Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065156
Status:
COMPLETED
Last Update Posted:
2019-11-19
First Post:
2003-07-17
Brief Title:
Lenalidomide SafetyEfficacy in Myelodysplastic Syndromes MDS Associated With a Deletion Del5q Cytogenetic Abnormality
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
CC-5013-MDS-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None